There is no longer any doubt: We are entering a mass extinction that threatens humanity's existence, according to a rather ridiculous claim by doomsday prophet Professor Paul Ehrlich, the same author of the Population Bomb who has been saying this same thing since the 1960s.

 Ehrlich and fellow hysterics Anthony D. Barnosky of the University of California at Berkeley, Andrés García of Universidad Autónoma de México, Robert M. Pringle of Princeton University and Todd M. Palmer of the University of Florida, say there are threatened species, too many humans, and issues with habitat. 

Every president for more than 30 years has required executive branch agencies to analyze regulatory impacts before issuing new requirements.

They’ve relied on the Office of Information and Regulatory Affairs (OIRA) in the Office of Management and Budget to review significant new rules to ensure the quality of such regulatory analysis.

New, ultra-high-field magnetic resonance images (MRI) of the brain provide the most detailed images to date to show that while the brain shrinks with age, brain cell density remains constant.

The images of cognitively normal young and old adults provide the first evidence that in normal aging, cell density is preserved throughout the brain, not just in specific regions, as previous studies on human brain tissue have shown. The findings also suggest that the maintenance of brain cell density may protect against cognitive impairment as the brain gradually shrinks in normal aging.

Doctors often misdiagnose zinc deficiency, and seem to be unaware of the impact of excess zinc on the body, according to a small audit of clinical practice.

Zinc is an essential trace element that is required in daily quantities of 5.5 to 9.5 mg for men, and 4 to 7 mg for women. But zinc supplements are usually only available in formulations of 45 or 50 mg. The US recommended tolerable limit is 40 mg/day.

I’m generally optimistic about the ability of the world’s farmers to continue to feed the growing population, and also to satisfy the increased food demand of the growing middle class in previously poor countries. That hope is based on the amazing track record of innovation by farmers and their technological supporters that I have witnessed over the past four decades. I do, however, have some significant concerns about trends and factors that may compromise the farming enterprise over the next critical decades.

Working women are "leaning in" and supporting more females in leadership roles, but a new study finds that having a female manager doesn't necessarily equate to higher salaries for female employees.

Instead, women can sometimes take an earnings hit relative to their male colleagues when they go to work for a female manager.

Melanoma patients with high levels of a protein that controls the expression of pro-growth genes are less likely to survive, according to a study led by researchers at Icahn School of Medicine at Mount Sinai and published online in the journal Molecular Cell.

The research team found that the protein, called H2A.Z.2, promotes the abnormal growth seen in melanoma cells as they develop into difficult-to-treat tumors. H2A.Z.2 is part of the chromosome structure that packages genes, and has the ability to switch them on off. Having high levels of this protein aberrantly activates growth-promoting genes in melanoma cells.

Gilles-Éric Séralini is a French scientist who has been a professor of molecular biology at the University of Caen since 1991.

Often referred to as the "body clock", circadian rhythm controls what time of day people are most alert, hungry, tired or physically primed due to a complex biological process that is not unique to humans. Circadian rhythms, which oscillate over a roughly 24-hour cycle in adaptation to the Earth's rotation, have been observed in most of the planet's plants, animals, fungi and cyanobacteria, and are responsible for regulating many aspects of organisms' physiological, behavioral and metabolic functions.

When a new type of drug or therapy is discovered, double-blind randomized controlled trials (DBRCTs) are the gold standard for evaluating them. These trials, which have been used for years, were designed to determine the true efficacy of a treatment free from patient or doctor bias, but they do not factor in the effects that patient behaviors, such as diet and lifestyle choices, can have on the tested treatment.